Financhill
Buy
57

NGVT Quote, Financials, Valuation and Earnings

Last price:
$58.66
Seasonality move :
-3.03%
Day range:
$58.17 - $59.97
52-week range:
$28.49 - $61.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.68x
P/B ratio:
15.26x
Volume:
772.5K
Avg. volume:
362K
1-year change:
43.83%
Market cap:
$2.1B
Revenue:
$1.4B
EPS (TTM):
-$1.83

Analysts' Opinion

  • Consensus Rating
    Ingevity Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $69.50, Ingevity Corp. has an estimated upside of 16.45% from its current price of $58.61.
  • Price Target Downside
    According to analysts, the lowest downside price target is $60.00 representing -2.37% downside risk from its current price of $58.61.

Fair Value

  • According to the consensus of 3 analysts, Ingevity Corp. has 16.45% upside to fair value with a price target of $69.50 per share.

NGVT vs. S&P 500

  • Over the past 5 trading days, Ingevity Corp. has underperformed the S&P 500 by -0.55% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Ingevity Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Ingevity Corp. revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Ingevity Corp. reported revenues of $333.2M.

Earnings Growth

  • Ingevity Corp. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Ingevity Corp. reported earnings per share of $1.18.
Enterprise value:
3.3B
EV / Invested capital:
--
Price / LTM sales:
1.68x
EV / EBIT:
11.47x
EV / Revenue:
2.56x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
13.71x
Price / Operating cash flow:
8.97x
Enterprise value / EBITDA:
8.42x
Gross Profit (TTM):
$456.6M
Return On Assets:
-3.43%
Net Income Margin (TTM):
-5.35%
Return On Equity:
-37.98%
Return On Invested Capital:
-4.28%
Operating Margin:
24.79%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $1.7B $1.4B $1.3B $333.8M $333.2M
Gross Profit $482.2M $377.1M $456.6M $124.7M $125.9M
Operating Income $295.3M $214.9M $286.5M $88.3M $82.6M
EBITDA $439.6M $323.1M $390.2M $114.5M $110.6M
Diluted EPS $3.43 -$15.53 -$1.83 -$2.95 $1.18
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $720.3M $645.1M $734.5M $636.8M $522.2M
Total Assets $2.4B $2.3B $2.8B $2.2B $1.8B
Current Liabilities $247.6M $290.3M $305.1M $360.8M $411.6M
Total Liabilities $1.8B $1.7B $2B $2B $1.7B
Total Equity $644.5M $633.9M $718.7M $214.5M $138.1M
Total Debt $1.3B $1.2B $1.5B $1.5B $1.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $258.7M $108.7M $298.6M $46.5M $129.7M
Cash From Investing -$465.5M -$72.5M -$70.4M -$17.4M -$28.1M
Cash From Financing $219.6M $20.9M -$266.4M -$6.3M -$94.8M
Free Cash Flow $128.9M $26.8M $239.6M $28.5M $117.8M
NGVT
Sector
Market Cap
$2.1B
$21M
Price % of 52-Week High
94.88%
70.59%
Dividend Yield
0%
0%
Shareholder Yield
3.98%
-2.61%
1-Year Price Total Return
43.83%
11.86%
Beta (5-Year)
1.396
0.621
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $58.68
200-day SMA
Buy
Level $47.57
Bollinger Bands (100)
Buy
Level 50.2 - 58.14
Chaikin Money Flow
Buy
Level 7.4M
20-day SMA
Buy
Level $54.87
Relative Strength Index (RSI14)
Buy
Level 61.98
ADX Line
Buy
Level 26.11
Williams %R
Neutral
Level -28.951
50-day SMA
Buy
Level $53.47
MACD (12, 26)
Buy
Level 1.93
25-day Aroon Oscillator
Buy
Level 64
On Balance Volume
Neutral
Level 18.6M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.1415)
Sell
CA Score (Annual)
Level (-1.1974)
Buy
Beneish M-Score (Annual)
Level (-4.2045)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (3.04)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Ingevity Corp. engages in the manufacture of specialty chemicals and carbon materials. It operates through the following segments: Performance Chemicals, Performance Materials and Advanced Polymer Technologies. The Performance Materials segment consists of automotive technologies and process purifications product families. Automotive technologies produce automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. Process purifications produce a number of activated carbon products for food, water, beverage and chemical purification applications. The Performance Chemicals segment primarily addresses applications in three product families: pavement technologies, oilfield technologies, and industrial specialties. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. The company was founded on March 27, 2015 and is headquartered in North Charleston, SC.

Stock Forecast FAQ

In the current month, NGVT has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The NGVT average analyst price target in the past 3 months is $69.50.

  • Where Will Ingevity Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Ingevity Corp. share price will rise to $69.50 per share over the next 12 months.

  • What Do Analysts Say About Ingevity Corp.?

    Analysts are divided on their view about Ingevity Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ingevity Corp. is a Sell and believe this share price will drop from its current level to $60.00.

  • What Is Ingevity Corp.'s Price Target?

    The price target for Ingevity Corp. over the next 1-year time period is forecast to be $69.50 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is NGVT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Ingevity Corp. is a Buy. 2 of 3 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of NGVT?

    You can purchase shares of Ingevity Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ingevity Corp. shares.

  • What Is The Ingevity Corp. Share Price Today?

    Ingevity Corp. was last trading at $58.66 per share. This represents the most recent stock quote for Ingevity Corp.. Yesterday, Ingevity Corp. closed at $58.61 per share.

  • How To Buy Ingevity Corp. Stock Online?

    In order to purchase Ingevity Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock